Senior insider sale
Chief Scientific Officer at CARISMA THERAPEUTICS INC. — senior position signals high conviction
$138.5K
541.33K shares
What this filing means
KLICHINSKY MICHAEL plans to sell 541.33K shares of CARISMA THERAPEUTICS INC. valued at approximately $138.5K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 10/6/2025ACC: 0001104659-25-097176
Officer· Chief Scientific Officer
Since Mar 2023
541.33K
Shares to sell
$138.5K
Approx. market value
56.98K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
Option Grant
Compensation
10/22/2018
56.98KTotal acquired56.98K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
10/22/2018 | Option Grant Compensation | 56.98K | — |
| Total | 56.98K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
484.35K
Market value
$124.3K
10/3/2025
Planned — Approximate Date
NASDAQPlanned
Units to sell
56.98K
Market value
$14.2K
10/7/2025
Total
Units
541.33K
Value
$138.5K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
10/3/2025 | 484.35K | $124.3K | — | Completed |
| Planned — Approximate Date | ||||
10/7/2025 | 56.98K | $14.2K | NASDAQ | Planned |
| Total | 541.33K | $138.5K | ||